Bank of America
NDRM

Bank of America’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Bank of America’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-134,306
Closed -$5.22M – 7576
2017
Q3 		$5.22M Buy
134,306
+125,942
+1,506% +$4.63M ﹤0.01% 3149
2017
Q2 		$250K Buy
8,364
+780
+10% +$20.2K ﹤0.01% 5220
2017
Q1 		$201K Sell
7,584
-979
-11% -$24.3K ﹤0.01% 5315
2016
Q4 		$190K Buy
8,563
+625
+8% +$11.7K ﹤0.01% 5350
2016
Q3 		$146K Sell
7,938
-1,576
-17% -$27.3K ﹤0.01% 5275
2016
Q2 		$155K Buy
9,514
+2,792
+42% +$47K ﹤0.01% 5333
2016
Q1 		$95K Sell
6,722
-4,170
-38% -$56.3K ﹤0.01% 5512
2015
Q4 		$185K Buy
10,892
+4,067
+60% +$79.2K ﹤0.01% 5427
2015
Q3 		$141K Buy
6,825
+6,325
+1,265% +$130K ﹤0.01% 5517
2015
Q2 		$8K Hold
500
– – ﹤0.01% 6689
2015
Q1 		$7K Buy
+500
New +$6.15K ﹤0.01% 6437

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Bank of America's NDRM Position: Q4 2017 in Review

Bank of America sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 134,306 shares — an estimated $5.22M sold.

Bank of America first reported a position in NDRM in Q1 2015 and held it in 11 quarters. The position peaked at $5.22M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Bank of America reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Bank of America sold 134,306 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $5.22M.
  • Bank of America first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2015 and held it in 11 quarters.
  • Bank of America's NeuroDerm Ltd. Ordinary Shares position peaked at $5.22M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.